1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Neuroscience Antibodies and Assays Market 2020-2024
The author has been monitoring the global neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The reports on global neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances. In addition, advances in neuroscience instruments is anticipated to boost the growth of the global neuroscience antibodies and assays market as well.
Market Segmentation
The global neuroscience antibodies and assays market is segmented as below:
Product
Geographic segmentation
Key Trends for global neuroscience antibodies and assays market growth
This study identifies advances in neuroscience instruments as the prime reasons driving the global neuroscience antibodies and assays market growth during the next few years.
Prominent vendors in global neuroscience antibodies and assays market
We provide a detailed analysis of around 25 vendors operating in the global neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The author has been monitoring the global neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The reports on global neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances. In addition, advances in neuroscience instruments is anticipated to boost the growth of the global neuroscience antibodies and assays market as well.
Market Segmentation
The global neuroscience antibodies and assays market is segmented as below:
Product
- Consumables
- Instruments
Geographic segmentation
- Asia
- Europe
- North America
- ROW
Key Trends for global neuroscience antibodies and assays market growth
This study identifies advances in neuroscience instruments as the prime reasons driving the global neuroscience antibodies and assays market growth during the next few years.
Prominent vendors in global neuroscience antibodies and assays market
We provide a detailed analysis of around 25 vendors operating in the global neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
01: EXECUTIVE SUMMARY07: CUSTOMER LANDSCAPE
02: SCOPE OF THE REPORT
03: MARKET LANDSCAPE
04: MARKET SIZING
05: FIVE FORCES ANALYSIS
06: MARKET SEGMENTATION BY PRODUCT
08: GEOGRAPHIC LANDSCAPE
09: DRIVERS AND CHALLENGES
10: MARKET TRENDS
11: VENDOR LANDSCAPE
12: VENDOR ANALYSIS
13: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abcam Plc
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Tecan Group Ltd.
The following companies as the key players in the global neuroscience antibodies and assays market: Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is advances in neuroscience instruments”
According to the report, one of the major drivers for this market is the technological advances.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is advances in neuroscience instruments”
According to the report, one of the major drivers for this market is the technological advances.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abcam Plc
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- F. Hoffmann-La Roche Ltd.
- GenScript Biotech Corp.
- Merck KGaA
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.137
Note: Product cover images may vary from those shown
